MERLONI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 511
EU - Europa 131
AS - Asia 48
AF - Africa 10
OC - Oceania 1
Totale 701
Nazione #
US - Stati Uniti d'America 511
IT - Italia 34
SE - Svezia 31
IE - Irlanda 27
CN - Cina 22
SG - Singapore 21
DE - Germania 11
GB - Regno Unito 11
UA - Ucraina 11
CI - Costa d'Avorio 10
FR - Francia 4
IN - India 3
DK - Danimarca 2
AU - Australia 1
JP - Giappone 1
KR - Corea 1
Totale 701
Città #
Chandler 86
Des Moines 81
Fairfield 42
Ashburn 39
Dublin 26
Jacksonville 26
New York 26
Wilmington 24
Seattle 19
Houston 16
Boardman 13
Cambridge 13
Woodbridge 11
Abidjan 10
Ann Arbor 10
Lawrence 10
Princeton 10
San Mateo 9
Singapore 8
Turin 7
Beijing 6
Falls Church 5
London 4
Washington 4
Cantu 3
Norwalk 3
Pune 3
San Diego 3
Caserta 2
Castelraimondo 2
Kilburn 2
Recanati 2
Bolton 1
Brisbane 1
Civitanova Marche 1
Cupra Marittima 1
Dangan 1
Jiaxing 1
Los Angeles 1
Mestre 1
Nanjing 1
Osimo 1
Qingdao 1
San Costanzo 1
Shaoxing 1
Sioux Falls 1
Southwark 1
Wuhan 1
Wuxi 1
Totale 542
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 88
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 88
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 84
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic 80
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 74
Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase 68
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 68
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC 62
Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience 53
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 53
Totale 718
Categoria #
all - tutte 3.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 1 0 1 0 2 0 1 1 1 5 8 11
2020/2021153 6 10 32 14 16 9 2 11 9 13 19 12
2021/202292 3 10 1 1 3 15 7 4 14 7 9 18
2022/2023272 19 25 15 23 10 101 0 9 44 1 18 7
2023/2024119 21 2 8 4 17 42 2 4 0 1 0 18
2024/202534 34 0 0 0 0 0 0 0 0 0 0 0
Totale 718